急性低氧性呼吸衰竭后的晚期死亡风险
该观察性队列研究基于美国健康与退休研究(HRS)中1998-2012年享受按服务收费医保的老年参与者,将因急性低氧性呼吸衰竭(AHRF)住院的患者与未住院成人及因急性诱因住院的患者进行匹配。主要结局为入院后31天至2年的晚期死亡。在存活至少30天的患者中,AHRF相对未住院成人的晚期死亡绝对风险增加24.4%,相对仅因急性诱因住院者增加6.7%。
要点
- AHRF存活者晚期死亡风险较未住院成人绝对增加24.4%。
- 急性诱因住院解释了晚期死亡风险增加的71.2%。
- AHRF本身仅解释晚期死亡风险增加的28.8%。
核心结论
- 在老年AHRF存活者中,约四分之一晚期死亡无法由AHRF前健康状况解释。
- 晚期死亡风险增加中超过70%与急性诱因住院相关,约30%与低氧性呼吸衰竭本身相关。
研究设计与样本
- 观察性队列研究,纳入美国HRS中1998-2012年享受按服务收费医保的老年参与者。
主要发现
- 在存活至少30天的患者中,AHRF相对未住院成人的晚期死亡绝对风险增加24.4%(95%CI 19.9%至28.9%,p<0.001)。
- AHRF相对仅因急性诱因住院者的晚期死亡绝对风险增加6.7%(95%CI 1.7%至11.7%,p=0.01)。
- 急性诱因住院解释了晚期死亡风险增加的71.2%,AHRF本身解释了28.8%。
- 90天后AHRF患者死亡风险与急性诱因住院者相当,但相对未住院对照在超过1年后仍升高。
临床怎么用
- 对AHRF存活者应关注晚期死亡风险,尤其需管理急性诱因相关疾病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute hypoxic respiratory failure (AHRF) is associated with significant acute mortality. It is unclear whether later mortality is predominantly driven by pre-existing comorbid disease, the acute inciting event or is the result of AHRF itself. METHODS: Observational cohort study of elderly US Health and Retirement Study (HRS) participants in fee-for-service Medicare (1998-2012). Patients hospitalised with AHRF were matched 1:1 to otherwise similar adults who were not currently hospitalised and separately to patients hospitalised with acute inciting events (pneumonia, non-pulmonary infection, aspiration, trauma, pancreatitis) that may result in AHRF, here termed at-risk hospitalisations. The primary outcome was late mortality-death in the 31 days to 2 years following hospital admission. RESULTS: Among 15 075 HRS participants, we identified 1268 AHRF and 13 117 at-risk hospitalisations. AHRF hospitalisations were matched to 1157 non-hospitalised adults and 1017 at-risk hospitalisations. Among patients who survived at least 30 days, AHRF was associated with a 24.4% (95%CI 19.9% to 28.9%, p<0.001) absolute increase in late mortality relative to adults not currently hospitalised and a 6.7% (95%CI 1.7% to 11.7%, p=0.01) increase relative to adults hospitalised with acute inciting event(s) alone. At-risk hospitalisation explained 71.2% of the increased odds of late mortality, whereas the development of AHRF itself explained 28.8%. Risk for death was equivalent to at-risk hospitalisation beyond 90 days, but remained elevated for more than 1 year compared with non-hospitalised controls. CONCLUSIONS: In this national sample of older Americans, approximately one in four survivors with AHRF had a late death not explained by pre-AHRF health status. More than 70% of this increased risk was associated with hospitalisation for acute inciting events, while 30% was associated with hypoxemic respiratory failure.
引用
- Prescott HC, Sjoding MW, Langa KM, et al. Late mortality after acute hypoxic respiratory failure. Thorax. 2017. PMID: 28780503. doi:10.1136/thoraxjnl-2017-210109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。